{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:36:49Z","timestamp":1773697009688,"version":"3.50.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00625","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:34:22Z","timestamp":1562718862000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial"],"prefix":"10.3389","volume":"9","author":[{"given":"Andreas","family":"Dietz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kuhnt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1200\/JCO.2018.77.8001","article-title":"Different view on larynx preservation evidence-based treatment recommendations","volume":"36","author":"Licitra","year":"2018","journal-title":"J Clin Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/hed.23326","article-title":"Efficacy of stapler pharyngeal closure after total laryngectomy: a systematic review","volume":"36","author":"Aires","year":"2014","journal-title":"Head Neck."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/lary.24466","article-title":"Fistula rates after salvage laryngectomy: comparing pectoralis myofascial and myocutaneous flaps","volume":"124","author":"Khan","year":"2014","journal-title":"Laryngoscope."},{"key":"B5","first-page":"162","article-title":"Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review","volume":"35","author":"Putten","year":"2015","journal-title":"Acta Otorhinolaryngol Ital."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1200\/JCO.2013.49.1332","article-title":"Larynx preservation: a debate worth preserving","volume":"31","author":"Haddad","year":"2013","journal-title":"J Clin Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/archotol.129.1.44","article-title":"Outcome of salvage total laryngectomy following organ preservation therapy","volume":"129","author":"Weber","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/MLG.0b013e3180332e39","article-title":"Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure","volume":"117","author":"Withrow","year":"2007","journal-title":"Laryngoscope."},{"key":"B9","first-page":"2","article-title":"Pharyngocutaneous fistula following total laryngectomy","volume":"27","author":"Dedivitis","year":"2007","journal-title":"Acta Otorhinolaryngol Ital."},{"key":"B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/hed.20502","article-title":"Histologic characteristics and tumor spread of recurrent glottic carcinoma: analysis on whole-organ sections and comparison with tumor spread of primary glottic carcinomas","volume":"29","author":"Zb\u00e4ren","year":"2007","journal-title":"Head Neck."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.ijrobp.2008.10.047","article-title":"Larynx preservation consensus panel: larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary","volume":"73","author":"Lefebvre","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/cncr.29241","article-title":"Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey","volume":"121","author":"Rosenthal","year":"2015","journal-title":"Cancer."},{"key":"B13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ijrobp.2015.03.004","article-title":"Total laryngectomy versus larynx preservation for t4a larynx cancer: patterns of care and survival outcomes","volume":"92","author":"Grover","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hed.23789","article-title":"T3-T4 laryngeal cancer in The Netherlands Cancer Institute: 10-year results of the consistent application of an organ-preserving\/-sacrificing protocol","volume":"37","author":"Timmermans","year":"2015","journal-title":"Head Neck."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00405-008-0697-6","article-title":"Current aspects of targeted therapy in head and neck tumors","volume":"265","author":"Dietz","year":"2008","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/annonc\/mdy102","article-title":"Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions","volume":"29","author":"Haddad","year":"2018","journal-title":"Ann Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation","volume":"101","author":"Pointreau","year":"2009","journal-title":"J Natl Cancer Inst."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00405-008-0846-y","article-title":"Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)","volume":"266","author":"Dietz","year":"2009","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol."},{"key":"B23","author":"Dietz","year":"2007","journal-title":"DeLOS-II. Randomised Phase II Screening Study to the Use of a TPF-Chemotherapy (Short Induction) Before TPF Induction, Radiotherapy With or Without Cetuximab in the Primary Therapy of the Only by Laryngectomy Operable Carcinoma of the Larynx\/Hypopharynx."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1055\/s-0038-1640003","article-title":"Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal\/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II","volume":"29","author":"Dietz","year":"2018","journal-title":"Ann Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00066-013-0411-5","article-title":"Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer","volume":"189","author":"Rutkowski","year":"2013","journal-title":"Strahlenther Onkol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1002\/ijc.29649","article-title":"The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer","volume":"137","author":"Wichmann","year":"2015","journal-title":"Int J Cancer."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1172\/JCI67010","article-title":"HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas","volume":"123","author":"Kostareli","year":"2013","journal-title":"J Clin Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/15592294.2015.1137414","article-title":"Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients","volume":"11","author":"Kostareli","year":"2016","journal-title":"Epigenetics."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/cncr.29188","article-title":"Single-cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: what are the best predictors of remission and prognosis?","volume":"121","author":"Semrau","year":"2015","journal-title":"Cancer."},{"key":"B31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejca.2016.11.013","article-title":"Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and 18F-FDG-PET\/CT","volume":"72","author":"Wichmann","year":"2017","journal-title":"Eur J Cancer."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","year":"1991","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaoncol.2017.4478","article-title":"Primary cancer vs competing causes of death in survivors of head and neck cancer","volume":"4","author":"Simpson","year":"2018","journal-title":"JAMA Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00106-011-2416-7","article-title":"Multimodaler Larynxerhalt. Wege zur besseren Patientenselektion [Multimodal laryngeal preservation. Current data-based opinion]","volume":"60","author":"Dietz","year":"2012","journal-title":"HNO."},{"key":"B35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group","volume":"88","author":"Lefebvre","year":"1996","journal-title":"J Natl Cancer Inst."},{"key":"B36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archotol.130.7.875","article-title":"Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation","volume":"130","author":"Hanna","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1200\/JOP.2016.014811","article-title":"Functional organ preservation in larynx cancer: a continuing debate","volume":"12","author":"Dietz","year":"2016","journal-title":"J Oncol Pract."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1200\/JCO.2017.75.7385","article-title":"American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer","volume":"24","author":"Pfister","year":"2006","journal-title":"J Clin Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1200\/JCO.2005.01.2047","article-title":"Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm","volume":"24","author":"Urba","year":"2006","journal-title":"J Clin Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00405-018-5241-8","article-title":"Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?","volume":"276","author":"Al-Mamgani","year":"2019","journal-title":"Eur Arch Oto-Rhino-Laryngol."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00625\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:34:24Z","timestamp":1562718864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00625\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":40,"alternative-id":["10.3389\/fonc.2019.00625"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00625","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,10]]},"article-number":"625"}}